Table 2.
Clinical data of patients
| Sample ID |
Surgery date (day/month/year)a |
Histology | Grade | Lymph node metastasis |
Stage | ER expression |
PR expression |
ERBB2 expression |
Ki67 expression |
Adjuvant therapy |
|---|---|---|---|---|---|---|---|---|---|---|
| 433 | 30/01/2013 (21) | lobular | 1 | absent | IIA | positive | positive | negative | 5% | TAM, AI |
| 434 | 01/02/2013 (21) | ductal | 3 | absent | Tis | positive | positive | negative | 20% | TAM, AI |
| 435 | 01/02/2013 (21) | ductal | 1 | absent | IA | positive | positive | negative | 10% | TAM, AI |
| 438 | 06/02/2013 (25) | ductal | 3 | present | IIB | negative | positive | negative | 30% | TAM |
| 440 | 08/02/2013 (21) | tubular | 1 | absent | IA | positive | positive | negative | 5% | AI |
| 443 | 13/02/2013 (21) | ductal | 3 | absent | IA | negative | negative | negative | 60% | none |
| 445 | 13/02/2013 (23) | ductal | 3 | absent | IIA | negative | negative | negative | 40% | AC, PCT |
| 452 | 22/02/2013 (23) | tubular | 1 | absent | I | positive | positive | negative | 10% | TAM |
| 453 | 27/02/2013 (24) | ductal | 1 | absent | I | positive | positive | negative | 5% | TAM |
| 456 | 01/03/2013 (20) | ductal | 1 | absent | I | positive | positive | negative | 20% | TAM |
| 463 | 13/03/2013 (24) | ductal | 1 | present | IIA | positive | positive | negative | 10% | EC, TAM |
| 473 | 22/03/2013 (20) | ductal | 3 | absent | I | negative | negative | positive | 30% | EC |
| 476 | 22/03/2013 (20) | ductal | 2 | absent | I | positive | positive | negative | 15% | TAM, AI |
| 500 | 03/05/2013 (18) | ductal | 3 | absent | I | positive | positive | negative | 30% | TAM, AI |
| 504 | 10/05/2013 (20) | tubular | 2 | absent | I | positive | positive | negative | 15% | TAM |
| 505 | 15/05/2013 (20) | ductal | 1 | absent | I | positive | positive | negative | 5% | TAM |
| 523 | 23/06/2013 (19) | ductal | 3 | absent | I | negative | negative | negative | 50% | EC |
| 535 | 10/07/2013 (16) | ductal | 2 | absent | IIA | positive | positive | negative | 20% | EC, TAM, AI |
| 590 | 23/09/2013 (14) | ductal | 3 | present | IIA | positive | positive | positive | 20% | EC, TXT, HER, TAM |
| 599 | 25/10/2013 (13) | mucinous | 1 | absent | IIA | positive | positive | negative | 15% | TAM |
| 600 | 01/11/2013 (15) | ductal | 3 | present | IIA | positive | positive | negative | 30% | EC, PCT, AI |
| 606 | 20/11/2013 (12) | ductal | 3 | absent | IA | negative | negative | negative | 60% | none |
| 611 | 29/11/2013 (14) | ductal | 2 | present | IIA | positive | positive | negative | 10% | EC, TAM |
| 614 | 13/12/2013 (11) | ductal | 1 | present | IIA | positive | positive | negative | 3% | TAM |
a
Sampling interval in months in parentheses
ER=estrogen receptor, PR=progesterone receptor, ERBB2=erb-b2 receptor tyrosine kinase 2, Ki67=proliferation-related Ki-67 antigen